Organizer Description: As a part of our mission, the Alliance for Regenerative Medicine (ARM) is committed to serving our membership in enabling the development of, and global access to, cell and gene therapies. Through ARM’s Managed Growth Working Group, an initiative aimed at identifying how ARM can refine and expand its work to better serve our member organization, ARM kicked off its Asia-Pacific (APAC) geographic expansion strategy in 2024. Based on ARM’s recent sector data, the APAC region is second to North America in the number of CGT developers, clinical trials, and investment, and is growing at twice the rate of North America and Europe.

To support the APAC geographic expansion strategy, we are excited to announce our upcoming APAC Virtual Summit: Cell & Gene Therapy Horizons, a half-day virtual workshop exploring the rapidly evolving landscape of cell and gene therapy (CGT) across the APAC region. This summit will provide insights into CGT development, regulations, and commercialization in APAC.

Participants will gain access to presentations, in-depth discussions and expert-led panels covering:

• Innovative Development: Hear from CGT developers and manufacturers on their development programs and paths to commercialization. Discover development paradigms tailored to regional needs.

• Regulatory Framework: Navigate the diverse and complex regulatory frameworks across APAC markets, with perspectives from leading health authorities and industry experts.

• Commercialization Strategies: Learn how to overcome market access challenges, build sustainable business models, and form strategic partnerships for successful CGT programs.